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Recent genome scans have established the presence of a major psoriasis-susceptibility locus in the human leukocyte
antigen (HLA) complex on chromosome 6p21.3. To narrow the interval for candidate gene testing, we performed
a linkage-disequilibrium analysis of 339 families, with the use of 62 physically mapped microsatellite markers
spanning the major histocompatibility complex (MHC). As detected by use of the transmission/disequilibrium test
(TDT), individual markers yielded signiﬁcant linkage disequilibrium across most of the MHC. However, the strong-
est evidence for marker-trait disequilibrium was found in an ∼300-kb region extending from the MICA gene to
the corneodesmosin gene. Maximum-likelihood haplotypes were constructed across the entire MHC in the original
sample and across a 1.2-Mb region of the central MHC in an expanded sample containing 139 additional families.
Short (two- to ﬁve-marker) haplotypes were subjected to the TDT using a “moving-window” strategy that reduced
the variability of TDT P values relative to the single-locus results. Furthermore, the expanded sample yielded a
sharp peak of evidence for linkage disequilibrium that spanned ∼170 kb and that was centered 100 kb telomeric
to HLA-C. The 1.2-Mb interval was further dissected by means of recombinant ancestral haplotype analysis. This
analysis identiﬁed risk haplotype 1 (RH1), which is a 60-kb fragment of ancestral haplotype 57.1, on all identiﬁable
HLA risk haplotypes. One of these haplotypes exhibits signiﬁcant linkage disequilibrium with psoriasis but does
not carry Cw6, which is the HLA allele most strongly associated with the disease. These results demonstrate that
RH1 is highly likely to carry the disease allele at PSORS1, and they exclude HLA-C and corneodesmosin with a
high degree of conﬁdence.
Introduction
Psoriasis is a common, inﬂammatory, and hyperprolifer-
ative skin disease of suspected immunopathogenesis,
with a strong genetic component (Elder et al. 1994;
Christophers and Mrowietz 1999). Several conﬁrmed
and putative genetic loci for psoriasis have been de-
scribed in the course of genome scanning (reviewed in
Bhalerao and Bowcock 1998). The locus of strongest
effect appears to reside within the major histocompati-
bility complex (MHC; Nair et al. 1997; Trembath et al.
1997; Burden et al. 1998; Leder et al. 1998). This locus
has been designated as “PSORS1” (MIM 177900). The
results of previous studies of linkage and/or association
(Trembath et al. 1997; Jenisch et al. 1998; Balendran et
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al. 1999; Oka et al. 1999) favor a location for PSORS1
in the class I or class III regions of the MHC, and strong
allelic associations between psoriasis and human leu-
kocyte antigen (HLA)–Cw6 have long been recognized
in case-control studies (Tiilikainen et al. 1980). Asso-
ciations between Cw6 and psoriasis are even more sig-
niﬁcant in juvenile-onset and familial psoriasis (Henseler
and Christophers 1985; Enerback et al. 1997; Jenisch et
al. 1998; Mallon et al. 1999). However, several lines of
evidence suggest that HLA-Cw6 is not the PSORS1-sus-
ceptibility allele (Jenisch et al. 1998; Leder et al. 1998;
Jenisch et al. 1999b). The most obvious evidence for this
is the fact that many psoriatics do not carry HLA-Cw6.
This could be explained by the existence of one or more
psoriasis-susceptibility gene(s) unlinked to theMHC (lo-
cus heterogeneity), with Cw6 directly responsible for dif-
ferent proportions of the disease in different populations.
However, locus heterogeneity cannot explain two other
key observations. First, different psoriasis-associated
HLA-Cw6-Bx haplotypes (Cw6-B57, Cw6-B13, and
Cw6-B37) appear to carry different risks in populations
that are widely separated in terms of geography and
ethnicity (Ozawa et al. 1981; Roitberg-Tambur et al.
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1994; Ikaheimo et al. 1996; Kim et al. 2000). Second,
there is at least one HLA Cw6-negative HLA-B/C hap-
lotype—Cw8-B65—that appears to segregate with pso-
riasis in some families (Jenisch et al. 1997).
An alternative explanation is that PSORS1 resides
near HLA-C, with the disease allele in strong linkage
disequilibrium with Cw6. Recently, strong associations
have been observed between psoriasis and “allele 5” of
corneodesmosin (CDSN [MIM 602593], originally
known as the “S gene”), which resides ∼160 kb telo-
meric to HLA-C (Zhou and Chaplin 1993; Allen et al.
1999; Tazi Ahnini et al. 1999). However, a more com-
plete description of the allelic variation at CDSN re-
vealed that allele 5 can be split into two alleles—known
as “CD2” and “CD3”—that differ only at a single nu-
cleotide (1215A/G). CD2 and CD3 were found only on
known psoriasis-associated haplotypes that also carry
HLA-Cw6: CD2 was found on Cw6-B57 and Cw6-B37,
and CD3 was found on Cw6-B13 (Jenisch et al. 1999a).
Thus, CDSN does not appear to account for risk of
psoriasis any better than does HLA-Cw6.
The ﬁnding of linkage disequilibrium is not speciﬁc
to psoriasis (or to other HLA-associated diseases), but
it is also observed, in normal individuals, across ∼3 Mb
of the MHC, extending from HLA-DQ to HLA-A (re-
viewed in Todd, in press). This is a reﬂection of the fact
that most modern-day HLA haplotypes can be ac-
counted for by ∼20 ancestral or extended haplotypes
and their recombinants (Degli-Esposti et al. 1992c).
These are designated as “EHxx.y,” where EH denotes
an extended haplotype, where xx refers to the HLA-B
allele carried by that haplotype, and where y refers to
identiﬁed variants of that haplotype. Both Cw6 and the
CD2 allele at CDSN are carried by the ancestral hap-
lotype designated as “EH57.1” (Jenisch et al. 1999a).
By making use of HLA types as markers, we (Jenisch
et al. 1998) and others (Schmitt-Egenolf et al. 1996)
have shown that familial psoriasis is associated with the
class I end of the EH57.1 haplotype.
In the complete sequence of the MHC, 224 gene
loci—128 of which are predicted to be expressed—have
been identiﬁed (MHC Sequencing Consortium 1999).
On the basis of the foregoing arguments, we suspected
that PSORS1 might be a gene other than HLA-C or
CDSN. We recognized that, although the HLA genes
are extremely polymorphic, they are not sufﬁciently
dense to map PSORS1 with high precision. To overcome
this limitation, we screened a large number of potential
polymorphisms identiﬁed from the emerging MHC se-
quence, and we used new and existing polymorphisms
to perform high-density genotyping of a large collection
of kindreds with familial psoriasis. In the present study,
we report several analyses of these genotypes, all of
which support localization of PSORS1 immediately
telomeric to HLA-C. The most powerful analytical
method proved to be recombinant ancestral haplotype
analysis. This method has previously been used to lo-
calize genes for insulin-dependent diabetes mellitus, my-
asthenia gravis, and Alzheimer disease as well as pso-
riasis (Todd et al. 1989; Degli-Esposti et al. 1992a;
Degli-Esposti et al. 1992b; Schmitt-Egenolf et al. 1996;
Jenisch et al. 1998). This analysis identiﬁed a 60-kb
fragment of EH57.1 that is highly likely to carry the
disease allele at PSORS1. This interval excludes both
HLA-C and CDSN with a high degree of conﬁdence.
Subjects and Methods
Study Population
The study cohort consisted of families identiﬁed
through the dermatology services of the University of
Michigan Medical Center, the Ann Arbor Veterans Af-
fairs Medical Center, the University of Kiel, and Henry
Ford Hospital. Additional families were provided by the
National Psoriasis Foundation Tissue Bank. On the basis
of the established correlation between juvenile onset and
a positive family history of psoriasis (Henseler and
Christophers 1985), only those families in which the age
at onset in the proband was !40 years were included.
Individuals were considered to be affected if chronic
plaque or guttate psoriasis lesions covered 11% of the
total body-surface area (TBSA) or if at least two skin,
scalp, nail, or joint lesions were clinically diagnostic of
psoriasis (Nair et al. 1997). Informed consent was ob-
tained from all subjects, under protocols approved by
the institutional review boards of the participating
institutions.
Markers and Genotyping
A set of 62 microsatellite markers spanning 3.5 Mb
was identiﬁed from published sources or by scanning of
MHC-sequence submissions for short-nucleotide repeats
(ﬁg. 1). A complete description of these markers is avail-
able from the Web site of the Psoriasis Genetics Labo-
ratory, Department of Dermatology, University ofMich-
igan. As measured on the physical map of the MHC
(available from the Sanger Centre Web site; see also
GenBank [accession number NT_001520]), the interval
studied extended from 350 kb (∼330 kb centromeric of
HLA-DQB1) to 3,845 kb (∼90 kb telomeric of histone
H4) (ﬁg. 1). The markers designated as “M6Sxxx” in
ﬁgure 1 were developed in our laboratory at the Uni-
versity of Michigan, on the basis of the available se-
quence of the region. These markers have been deposited
in the Genome Database. All other markers were iden-
tiﬁed from the Genome Database and are identiﬁed, in
ﬁgure 1, by their assigned primary names in the Genome
Database.
DNA was prepared from blood samples or from Ep-
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Figure 1 Physical map of the HLA complex, showing the microsatellite markers used in the present study. The map coordinates are based
on the 3,838,986-bp consensus map available at the Sanger Centre Web site. The positions of the markers indicate the centromeric end of the
amplimers, and the positions of the genes indicate the translation start codons. Positions of RH1 and RH2 are also indicated (see text for
details).
stein-Barr virus–immortalized lymphoblasts and were
genotyped as described elsewhere (Nair et al. 1995). Ge-
notyping was performed on 478 families, each of which
contained at least one affected individual with at least
one typed parent. The primary sample, which consisted
of 339 families, was typed for all 62 markers. An ad-
ditional 139 families were typed for the middle 34 mark-
ers spanning 1.2 Mb, from 1,575 to 2,775 kb. The com-
bined cohort of 478 families will be referred to as the
“expanded sample” (table 1).
Allele sizes were determined by inspection of auto-
radiograms. When available, published allele sizes for
CEPH individual 134702 (available at the Center for
Medical Genetics, Marshﬁeld Medical Research Foun-
dation Web site) were used as a reference. For the newly
developed markers, allele sizes of the reference standard
were assessed by use of the SeqaMark DNA-sequencing
ladder (Research Genetics). Genotyping problems caus-
ing Mendelian inheritance errors were discovered, and
allele-frequency ﬁles were created with the use of PED-
MANAGER and the LINKAGE package (Terwilliger
and Ott 1994). Additional error checking was accom-
plished by means of visual inspection of the marker hap-
lotypes generated by GENEHUNTER (see the Haplo-
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Table 1
Families Utilized in the Present Study
FAMILY
SAMPLE
Primary Expanded
Nucleara 110 130
Extendedb 81 97
Singletonc 148 251
Unrelated trios:
With both parents 262 381
With one parent 77 97
Total, unrelated trios 339 478
a Two or more siblings with at least one parent
available.
b Pedigrees with more than one nuclear family in
two or more generations.
c An affected individual with one or both parents.
type Construction and Clustering section, below) for
double recombinants.
Some individuals were also subjected to HLA and
CDSN typing. HLA-C, HLA-DR, HLA-DQ, and CDSN
typings were performed by means of DNA-based meth-
ods, and HLA-B types were determined serologically, as
described elsewhere (Jenisch et al. 1998; Jenisch et al.
1999a).
Haplotype Construction and Clustering
Maximum-likelihood haplotypes for pedigrees were
determined by use of GENEHUNTER, version 1.1, with
the settings “max bits = 16” and “skip large = off”
(Kruglyak et al. 1996). All uncertain phase assignments
were detected and were converted to missing values.
Clusters of short haplotypes were formed by use of a
“moving-window” strategy, with the window length
varying from two to seven contiguous markers. Phase
and allele number had to be known at all marker po-
sitions within the window, and no mismatches were al-
lowed. A minimum of 10 founders were required to
create a cluster in any given window. All founder hap-
lotypes that fell into smaller groups or that had less than
full characterization were lumped together into a single
cluster for that window. The window was moved across
the MHC one marker at a time, from centromere to
telomere, and clustering was repeated for each window.
Clusters of long haplotypes were generated by use of
an average-distance agglomerative hierarchical method
with a percent difference metric, with the use of SYSTAT
for Windows, release 8.0.3 (SPSS). Each long haplotype
was comprised of 34 contiguous markers. To qualify for
clustering, at least half of the alleles of a long haplotype
were required to be typed and of known phase (180%
of the marker alleles were of known phase and were
typed in 95% of the founder haplotypes). Untyped or
phase-uncertain alleles were labeled as “missing,” rather
than as “zero,” to avoid false matches and mismatches.
The criteria for assignment to a cluster were 80% ho-
mogeneity of the haplotypes within the cluster and a
minimum of ﬁve founders. All smaller clusters were
lumped together into a single cluster.
Clusters of short and long founder haplotypes were
numbered and were assigned to all nonfounders in the
pedigrees. Any recombination within the portion of the
haplotype subjected to analysis caused it to be discarded
for all individuals inheriting the recombinant haplotype.
HLA-B, HLA-C, HLA-DR, HLA-DQ, and CDSN
alleles were not incorporated directly into either the
long-haplotype determinations performed by GENE-
HUNTER or the haplotype-clustering algorithms. Al-
leles at these loci were assigned to haplotypes by in-
spection of the informative pedigrees.
Disequilibrium Testing
The transmission/disequilibrium test (TDT) was used
for the determination of linkage disequilibrium between
psoriasis and alleles at individual loci as well as between
psoriasis and haplotypes generated by clustering. The
multiallelic Tmhet statistic (Spielman and Ewens 1996)
was used for the single-marker and short-haplotype
scans. The biallelic TDT statistic (Spielman et al. 1993)
was used for testing of individual haplotype clusters. In
all analyses, only one trio per family was used. When
more than one trio was present in a single family, we
used the most fully typed trio. If a pedigree contained
more than one equally typed trio, then one trio was
randomly selected. Because results varied somewhat, de-
pending on the seed used for the random-number gen-
erator, the analysis was repeated 15 times. For each
marker, haplotype window, or haplotype, the run yield-
ing the median P value is reported. Trios with only one
typed parent were handled as recommended by Curtis
and Sham (Curtis and Sham 1995). Inferred haplotypes
and genotypes for untyped parents were not used for
the TDT, because of the potential for bias (Curtis 1997).
However, they were used when clustering founder hap-
lotypes.
Pseudosupport intervals were determined with the
use of a criterion of 3.0 log10 units. This criterion
is akin to a 95% conﬁdence interval for 62 tests, since
log10 (0.05/62) = 3.09. The interval was then con-
servatively extended by one marker outward from the
last qualifying marker on either side. This criterion
does not deﬁne a statistically valid support interval;
to our knowledge, no such method exists for linkage-
disequilibrium studies. However, it does provide a rea-
sonable and objective method for comparison of the
results of different analyses.
For recombinant-haplotype analysis of two contigu-
ous haplotype fragments derived from one long ancestral
haplotype, we extracted all founder haplotypes thatwere
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Figure 2 Multiallelic TDT analysis of the MHC region (primary
sample). Top, TDT results for individual markers. Blackeneddiamonds
indicate markers characterized by heterozygosity 10.7. The corre-
sponding values for a three-marker haplotype window (middle) and
the corresponding values for a ﬁve-marker haplotypewindow(bottom)
are also shown. The midpoints of the three- and ﬁve-marker haplotypes
are plotted on the X-axis.
fully characterized for all markers comprising the two
fragments. These haplotypes were then grouped accord-
ing to whether they perfectly matched either or both of
the haplotype fragments; a mismatch was scored if at
least one allele within the fragment differed from the
parental haplotype. Each of these groups was then com-
pared for risk, by use of the biallelic TDT.
Comparison of Disease Phenotypes in Genetically
Deﬁned Subsets
Psoriatics that carried the risk haplotype (RH) iden-
tiﬁed by the aforementioned studies were comparedwith
psoriatics that did not carry the RH, with respect to age
at onset, percentage of TBSA involved, presence or ab-
sence of nail involvement, and presence or absence of
arthritis, as determined by history or physical exami-
nation. One RH-positive and one RH-negative affected
individual were randomly selected from each family.
Only one individual was selected from those families in
which all affected individuals were either RH-positive
or RH-negative. The distributions for TBSA and age at
onset were compared with the use of the Kolmogorov-
Smirnov two-sample test; nail involvement and arthritis
were analyzed by means of a contingency test.2x
Results
Single-Marker TDT
As shown in the top panel of ﬁgure 2, the plot of Tmhet
P values as a function of physical map position in the
MHC reveals linkage disequilibrium with psoriasis
throughout much of the HLA region. For the primary
sample of 339 families used in analysis of the entire
MHC, the two most distant markers yieldingmultiallelic
TDT were separated by a distance of 3.0 Mb,P  .05
extending from M6S229 (map position 465 kb) to
M6S213 (map position 3,468 kb). TDT wasP  .05
found for 43/57 markers spanning this region. After
Bonferroni correction was done for 62 single-marker
tests, the two most distant markers yielding P  .05
were separated by a distance of 2.3 Mb, extending from
just telomeric of HLA-DQB1 (D6S2447; 692 kb) to 270
kb centromeric of HLA-A (M6S204; 3,008 kb). Cor-
rected TDT was found for 26/46 markers span-P  .05
ning this region. The range of the uncorrected multial-
lelic TDT P value was 0.5– , with substantial1010
variation found even for closely spaced markers. How-
ever, many of the markers yielding less signiﬁcant P val-
ues were of low heterozygosity and, therefore, were less
likely to be unique to the disease chromosome (ﬁg. 2,
top [unblackened diamonds]). Nevertheless, a peak was
clearly evident in the data (ﬁg. 2). The pseudosupport
interval for this peak was 303 kb long and extended
from 25 kb centromeric of HLA-B (M6S166; 1,909.4
kb) to 40 kb telomeric of CDSN (M6S161; 2,212.1 kb).
This interval was subjected to additional analysis in the
expanded sample of 478 families. In the expanded sam-
ple, the six markers yielding the most signiﬁcant TDT
P values were all contained within the 303-kb region
identiﬁed by the primary sample (data not shown). Five
of these markers yielded multiallelic TDT P ! 5#
, which is nearly four orders of magnitude more1410
signiﬁcant than the P value of any marker lying outside
the 303-kb interval.
Short-Haplotype TDT
Multiallelic TDT P values were determined for two-
to ﬁve-marker haplotypes, in both the primary and ex-
panded samples; results for three- and ﬁve-marker hap-
lotypes in the primary sample are shown (ﬁg. 2, middle
and bottom). The P value plots were much less “jagged”
for the short haplotypes than for the single markers, and
the disparity between low and high P values within the
region of strongest disequilibrium steadily decreased as
the haplotype window increased up to ﬁve markers. In
the expanded sample, narrowing of the pseudosupport
interval to ∼170 kb was observed as the length of the
haplotype window increased from two to four markers.
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Table 2
Haplotype Clusters (Expanded Sample) and Their Transmission to Affected Offspring
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M
6
S
1
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1
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M
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S
2
0
1 T:NT (%T) P
Risk:
17 4 5 2 3 4 3 65 5 2 8 13 3 2 3 6 1 3 1 1 9 3 2 3 8 3 10 4 16 ) 1 2 6 3 6 15 14 21:10 (67.7) .048
19 2 5 5 3 4 6 ) 16 3 6 9 3 2 3 6 1 3 1 1 9 3 4 3 1 2 2 2 4 8 2 1 4 3 5 3 10 16:5 (76.2) .016
21 3 5 7 7 3 5 13 16 3 6 15 3 2 3 6 1 3 1 1 9 2 4 3 1 2 2 2 4 16 1 2 7 8 9 3 3 49:21 (70.0) .00082
22 3 5 7 7 3 5 13 16 3 6 15 3 2 3 6 1 3 1 1 9 2 4 3 1 2 2 2 4 16 1 2 4 5 12 ) ) 15:10 (60.0) .32
23 6 5 9 9 3 10 37 15 3 6 13 3 2 3 6 1 3 1 1 8 2 4 3 1 2 2 2 4 26 1 2 4 5 12 8 5 22:9 (71.0) .020
25 6 12 2 12 5 9 57 15 3 6 13 3 2 3 6 1 3 1 1 8 2 4 3 1 2 2 2 4 20 1 2 4 5 12 8 5 104:27 (79.4) 1.7 # 1011
Nonrisk:
14 6 5 11 6 3 5 7 9 3 7 1 6 ) 5 1 3 3 1 1 4 4 6 3 2 2 2 2 4 23 2 2 5 2 5 3 5 57:87 (39.6) .012
26 8 3 2 16 3 12 8 7 3 7 15 3 5 3 6 1 3 1 1 10 2 4 3 6 2 1 2 4 1 1 2 7 2 6 3 16 53:64 (45.3) .31
30 5 5 5 12 5 13 35 19 2 4 10 3 1 3 6 5 2 2 2 2 4 4 3 6 14 8 4 1 19 1 1 6 2 6 1 10 10:16 (38.5) .24
44 3 4 4 16 3 13 60 12 2 3 15 3 7 6 6 5 2 2 4 2 1 6 3 8 2 3 2 4 11 2 1 6 2 8 4 9 5:15 (25.0) .025
48 6 9 2 10 2 1 62 14 2 3 15 3 8 6 6 5 2 2 4 2 1 6 3 8 2 2 2 4 11 2 1 6 2 6 4 11 12:21 (36.4) .12
54 4 14 10 6 1 10 55 9 2 3 13 3 9 7 6 7 2 2 4 2 1 6 3 8 2 2 2 4 11 2 1 8 2 6 2 ) 11:11 (50.0) 1.00
56 4 4 7 7 4 5 44 3 2 16 15 3 9 6 6 5 2 2 4 2 1 5 3 6 2 1 2 3 20 2 1 6 3 3 3 5 19:22 (46.3) .64
58 4 4 7 7 4 5 44 11 2 4 8 7 1 3 6 5 2 1 1 4 4 6 4 6 6 8 4 16 18 1 2 5 2 6 3 15 8:11 (42.1) .49
63 5 9 6 3 3 15 44 4 2 5 10 3 13 7 3 3 1 1 1 2 4 5 4 8 13 13 4 1 ) 1 2 4 2 6 1 12 16:27 (37.2) .093
66 5 9 10 17 5 3 38 14 3 12 2 3 12 7 2 3 1 2 6 9 5 5 3 8 20 8 4 16 8 1 2 6 2 6 8 ) 15:15 (50.0) 1.00
61 2 6 4 3 2 3 65 6 2 8 8 7 13 1 1 1 3 1 1 5 2 5 4 4 14 6 4 17 13 1 2 6 5 12 ) ) 2:6 (25.0) )
NOTE.—All 34 markers subjected to long-haplotype clustering are displayed, in centromeric to telomeric order, from left to right. CDSN is located in RH2,
between markers M6S190 and M6S161. Ellipses ()) indicate that no allele occurred in 150% of the founder haplotypes comprising the cluster. Italicized numbers
indicate that the allele shown occurred in 50%–80% of the founder haplotypes comprising the cluster. Nonitalicized numbers indicate that the allele shown occurred
in 180% of the founder haplotypes comprising the cluster. Only the conserved alleles of RH1 and RH2 are denoted by the left and right boxes, respectively. Alleles
at HLA-B and HLA-C are indicated in boldfaced type.
a All risk clusters for which and the 10 most common nonrisk clusters are shown. Cluster 61 is shown for purposes of comparison with cluster 17TNT 10
(see text for details). No P value is given for cluster 61, because of an insufﬁcient number of occurrences.
This interval was centered at ∼2,130 kb and extended
from 30 kb telomeric of HLA-C (M6S167; 2,048.5 kb)
to 40 kb telomeric of CDSN (M6S161; 2,212.1 kb). This
region lies fully within the 303-kb region deﬁned by
single-marker analysis. The interval did not decrease fur-
ther when the window length was increased to ﬁvemark-
ers, suggesting a limit to the resolution of this type of
analysis as window length is increased.
Long-Haplotype Clustering and Delineation of Shared
RHs
The expanded sample of 478 families was typed for
34 markers extending from 360 kb centromeric of HLA-
B (D6S273; 1,577.3 kb) to 50 kb telomeric of HLA-E
(M6S201; 2,777.5 kb). This 1.2-Mb segment contains
the 303-kb candidate region deﬁned by single-marker
analysis, the 170-kb interval deﬁned by short-haplotype
analysis, and all markers that gave multiallelic TDT
. Maximum-likelihood haplotypes were gen-5P  10
erated with the use of GENEHUNTER, and 2,156 foun-
der haplotypes were clustered as described in the Sub-
jects and Methods section. This procedure delineated 66
founder haplotype clusters, which were numbered and
then were assigned to all members of the pedigrees.
Twenty-six of these clusters exhibited at least 10 inde-
pendent transmissions plus nontransmissions from het-
erozygous parents to affected children and were there-
fore capable of yielding a statistically valid TDT result.
Of these 26 clusters, 6 (clusters 17, 19, 21–23, and 25)
appear to impart an increased risk for psoriasis, when
risk is deﬁned as60% transmission to affected children
(table 2). For comparison, the 10 most common nonrisk
haplotypes are also shown in table 2, along with one
cluster (cluster 61) that will be discussed later.
Interestingly, by use of the clustering program, the
RHs were assigned similar identifying numbers, whereas
the 20 nonrisk haplotype clusters were all numbered as
!17 or 125. Because the clustering algorithm serially
orders the branches within the clustering tree to ensure
that the most similar haplotypes are closest to each other,
the contiguity of all RHs within the tree implies that
these haplotypes are more similar to each other, in terms
of marker-allele composition, than they are to any of
the nonrisk haplotypes. On the basis of this observation,
all haplotypes occurring too infrequently to have their
own cluster but falling between clusters 17 and 25 in
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Figure 3 Short-haplotype biallelic TDT analysis (expanded sam-
ple). Both panels refer to data obtained for a seven-marker moving
window. Symbols are plotted at the midpoint of each window. Perfect
matches to cluster 25 constituted one allele, and all other haplotypes
constituted the other allele. Top, Number of transmissions, to affected
offspring, of the EH57.1 haplotype fragment within the moving win-
dow. Bottom, log10 of the TDT P value for the EH57.1 haplotype
fragment contained within the moving window.
the ordered dendrogram were grouped and were tested
en masse by TDT. They, too, were found to carry risk
(66.0% transmission; ). Inspection of the cor-P = .011
responding HLA types revealed that ∼90% of the ev-
aluable haplotypes in this group carried Cw6, together
with various HLA-B alleles (alleles 13, 18, 37, 38, 44,
45, 57, 60, and 62). Most of the remaining evaluable
haplotypes carried Cw8 and B65.
Inspection of the consensus-allele composition of the
RHs revealed that they share all or part of a 185-kb
region just telomeric of HLA-C. All RHs (including those
that are too infrequent to fall within a testable cluster)
share an identical allele sequence for an eight-marker
region extending 42.5 kb from M6S105 to M6S143 (ta-
ble 2). When extended to the ﬁrst nonconserved ﬂanking
markers, this becomes a 59.4-kb segment extending
from M6S167 to M6S111 (2,048.5–2,107.9 kb). We
will refer to this haplotype as “RH1” (ﬁg. 1). Of the
RH clusters, all but one (cluster 17) share an identical
allele sequence over a seven-marker region extending a
distance of 93.5 kb, from M6S200 to M6S162; this be-
comes a 126.6-kb segment when it is extended to the
ﬁrst nonconserved ﬂanking markers, M6S169 and
M6S224 (2,109.9–2,236.5 kb). We will refer to this hap-
lotype as “RH2.” All RHs—except for cluster 17—also
share Cw6, although they carry a nonconserved marker
(M6S167) between HLA-C and RH1.
Veriﬁcation of RH1 and RH2 by Short Haplotypes
That Perfectly Match EH57.1
Long-haplotype cluster 25 was determined to repre-
sent the alleles carried by EH57.1, because nearly all
founder haplotypes in this cluster carry HLA-Cw6, B57,
DR7, and DQ9, which are the expected EH57.1 alleles
at these loci. Moreover, this cluster was very homoge-
neous: for 29/34 markers, the consensus allele was pres-
ent in 95% of the founder haplotypes. Agreement with
the consensus dropped toward the telomeric end of the
cluster, since only 75%–89% of the haplotypes matched
the consensus for the four most telomeric alleles. The
remaining exception was M6S224, which appears to
have a higher-than-normal mutation rate. It is hetero-
geneous in most clusters, and it produced nine apparent
mutations in our sample, compared with two or fewer
mutations seen for any of the other 33 markers within
the 1.2-Mb region. Since long-haplotype cluster 25 is
the most common RH in our sample and since it clearly
derives from EH57.1, it is reasonable to assume that
other risk clusters, which match EH57.1 only nearHLA-
C, derive their matching fragments from EH57.1 as well.
On the basis of this assumption, a more powerful dis-
equilibrium test is made possible by focusing only upon
transmission of fragments of the EH57.1 haplotype,
which is represented by long-haplotype cluster 25. For
this purpose, we used the 1.2-Mb region extending from
D6S273 to M6S201 to analyze the expanded sample of
478 families. Overlapping seven-marker haplotypes
were tested with the use of a bialleleic TDT (i.e., EH57.1
vs. non-EH57.1) using the moving-window strategy de-
scribed in the Subjects and Methods section. This win-
dow length was chosen because seven-marker haplo-
types are long enough to provide reasonable assurance
of IBD without being so long as to greatly reduce the
number of evaluable haplotypes caused by missing
marker genotypes or phase-uncertain alleles. This is also
approximately the length of RH1 and RH2.
Graphs were produced for the number of transmis-
sions to affected children and for the log10 P value for
transmission of these haplotypes from heterozygous par-
ents to affected offspring (ﬁg. 3). We found a high level
of linkage disequilibrium between psoriasis phenotype
and EH57.1 genotype across the entire 1.2-Mb region
(75%–80% transmission of seven-marker fragments of
EH57.1 to offspring [data not shown]). However, the
number of transmissions to affected individuals in-
creased from a steady background of 60–80 to ∼190 as
the window passed through the two RH regions, with
a distinct valley occurring between them (ﬁg. 3, top).
The corresponding signiﬁcance levels increased by seven
orders of magnitude across RH1 and by ﬁve orders of
magnitude across RH2, when compared with the re-
mainder of the 1.2-Mb region (ﬁg. 3, bottom). These
results indicate that many affected individuals in our
sample inherited a large DNA segment found on the
EH57.1 ancestral haplotype, and they explain why link-
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age disequilibrium with psoriasis is seen throughout
much of the MHC region. However, sufﬁcient ancestral
recombinations have occurred to leave only RH1 and
RH2 to be shared by the great majority of affected in-
dividuals inheriting any portion of the EH57.1 haplo-
type represented by cluster 25.
Comparison of Disequilibrium for RH1 and RH2 on
Ancestral Haplotype EH57.1
As shown in table 2, only RH1 is found in all iden-
tiﬁable RHs, suggesting that RH1—not RH2—is likely
to harbor PSORS1. However, the exclusion of RH2
(and, for that matter, HLA-C) as a candidate rests upon
a single RH: cluster 17. Moreover, cluster 17 yields a
21:10 transmitted:nontransmitted (T:NT) ratio in the
TDT (67.7% transmission), suggesting genuine risk, al-
beit with marginal signiﬁcance (uncorrected ).P = .048
To better compare the risk conferred by these two
regions, we grouped haplotypes according to whether
they perfectly matched either or both of the RH regions.
This increased the power of the analysis, by including
all haplotypes containing either of the two risk regions
and not just those that happened to fall into a cluster
containing at least ﬁve founders. Disequilibrium with
psoriasis was then assessed for each haplotype group,
by use of a biallelic TDT for independent trios. Hap-
lotypes carrying both RH1 and RH2 showed strong
preferential transmission to affected offspring (T:NT
150:41, transmission 78.5%; ). Haplo-15P = 3.1# 10
types carrying RH1 but not RH2 also showed strong
preferential transmission (T:NT 28:11, transmission
71.8%; ), whereas haplotypes carrying RH2P = .0065
but not RH1 did not (T:NT 6:9, transmission 40%;
).Moreover, the transmission ratios for the “RH1P = .44
only” and “RH2 only” groups were signiﬁcantly differ-
ent, despite small sample size ( ). These resultsP = .030
are in agreement with the long-haplotype analysis, in-
dicating that RH1—not RH2—harbors the disease
locus.
Phenotypic Analysis of RH1-Positive versus RH1-
Negative Psoriatics
To determine whether genetic heterogeneity exists in
the sample in the present study, we compared RH1-pos-
itive and RH1-negative psoriatics for their age at onset,
TBSA involvement, nail involvement, and arthritis, as
described in the Subjects and Methods section, above.
Psoriatics carrying RH1 ( ) had a signiﬁcantly dif-n = 320
ferent age-at-onset distribution ( ), with aP = .00125
lower mean age (19.7 vs. 23.9 years), a lower SD (12.1
vs. 15.1 years), and a more skewed distribution (positive
skew 1.03 vs. 0.94), compared with psoriatics lacking
RH1 ( ). No signiﬁcant differences were seen forn = 226
the other three variables.
Discussion
Because several preexisting lines of evidence had sug-
gested that PSORS1 might be a novel gene in the HLA
class I region, we used the emerging human MHC se-
quence to develop a set of polymorphic markers that
covered the MHC but were densest in the class I region.
We then used these markers to type 339 families ascer-
tained on the basis of juvenile-onset psoriasis in the pro-
band. Analysis of these data, with use of the single-locus
TDT, identiﬁed a peak of linkage disequilibrium thatwas
centered just telomeric of HLA-C. A 1.2-Mb interval
encompassing this peak was genotyped in an additional
139 families. Although TDT analysis of two- to four-
marker haplotypes narrowed the width of the peak to
170 kb, ﬁve-marker haplotypes yielded no further lo-
calization, signaling a limit to the usefulness of haplo-
type-based TDT analysis. To further localize PSORS1,
we turned to recombinant ancestral haplotype analysis.
Use of a dense marker map to identify recombinants of
an ancestral haplotype known to carry a disease gene is
a powerful analytical tool, since comparison of recom-
binant haplotypes in unrelated individuals with psoriasis
permits the study of a much larger number of infor-
mative recombinants than would typically be identiﬁed
by a family study (Xiong and Guo 1997; Schork et al.
1998).
To identify long haplotypes shared across families,
we applied cluster analysis, requiring 80% similarity
and at least ﬁve founders per cluster. All RHs identiﬁed
by biallelic TDT proved to be identical at the eight
internal markers of RH1, which is a 59.4-kb segment
encompassing these markers plus ﬂanking markers
M6S167 and M6S111. Moreover, all but one of the
RHs were identical at the seven internal markers of
RH2, which is a 126.6-kb segment encompassing these
markers plus ﬂanking markers M6S169 and M6S224
(table 2). When extended to their ﬂanking nonconserved
markers, as deﬁned in the Subjects andMethods section,
RH1 and RH2 are nearly contiguous, since they are
separated only by the 2-kb interval between M6S111
and M6S169 (ﬁg. 3). In aggregate, RH1 and RH2 cor-
responded closely to the 170-kb peak of linkage dise-
quilibrium identiﬁed by haplotype-based TDT.
Cluster analysis is robust to missing data, marker
mutation, and occasional genotyping errors. However,
it carries the risk that similar haplotypes that are not
IBD could be scored as IBD by the clustering algorithm.
(This could be a problem even when all markers are
fully characterized and when the cluster is 100% ho-
mogeneous, but this is unlikely.) Even though uninten-
tional inclusion of a non-IBD haplotype would be pre-
dicted to weaken, rather than strengthen, the TDT
results, it was still a concern. As a safeguard against
false IBD assignment, we employed two methods of
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short-haplotype analysis that required a perfect match
to a predeﬁned haplotype. This strategy also allowed
for the inclusion of rare haplotypes excluded from the
long-cluster analysis, thereby increasing power. The re-
sults of these analyses conﬁrmed the existence of two
RHs and demonstrated that RH1 is the minimal shared
region common to all RHs. Moreover, all testable hap-
lotypes that carry RH1 also carry risk for psoriasis.
Taken together, these ﬁndings indicate that RH1 is
highly likely to carry the disease allele at PSORS1.
RH1 extends from 29.2 to 88.6 kb telomeric of HLA-
C and is found on at least one Cw6-negative haplotype
cluster (Cw8-B65-CD1a; cluster 17). We have previ-
ously observed that the Cw8-B65 haplotype appears to
segregate with psoriasis in some—but not in all—
families (Jenisch et al. 1997). Although other plausible
explanations exist (even cluster 25 does not demonstrate
perfect segregation in the families under investigation),
this observation may be explained by our identiﬁcation
of two distinct clusters carrying Cw8 and B65, only one
of which carries RH1 (compare clusters 17 and 61 in
table 2). Taken together, these studies deﬁnitively rule
out HLA-C as PSORS1 for the ﬁrst time. These studies
also rule out several other nearby telomeric genes, in-
cluding PG8, POU5F1, TCF19, and CDSN (ﬁg. 1). Con-
sistent with this ﬁnding, DNA sequencing of coding
regions has failed to reveal any disease-speciﬁc sequence
variations in the POU5F1 and TCF19 genes (R.P.N.,
P.S., N.V.C.C., and J.T.E., unpublished observations).
Consistent with the fact that CDSN is contained within
the boundaries of RH2 (ﬁg. 1), cluster 25 (EH57.1) and
cluster 17 differ at their CDSN alleles, with cluster
25–positive individuals carrying CD2 and with cluster
17–positive individuals carrying CD1a (Jenisch et al.
1999a; additional data not shown].
Only 61% of the affected individuals in our sample
carry an identiﬁable copy of RH1. The remaining 39%
of individuals may: (1) carry the same disease allele IBD
at PSORS1, although the retained portion of RH1 may
be too small to be identiﬁed by our analysis; (2) carry
different disease allele(s) at PSORS1 that are represented
too few times to be recognized; or (3) carry no disease
allele at PSORS1. Consistent with prior associations be-
tween Cw6 and age at onset (Henseler and Christophers
1985), in the present study, stratiﬁcation of the popu-
lation for RH1 yielded a signiﬁcant difference in the
age-at-onset distribution. On the basis of these results,
it is reasonable to conclude that heterogeneity exists in
sample in the present study; however, we cannot distin-
guish between allelic heterogeneity, locus heterogeneity,
and the existence of nongenetic causes. At the same
time, these results also suggest that the disease allele
carried on RH1 is a major determinant of psoriasis,
since it is capable of exerting a detectable effect on the
phenotype. The importance of RH1 is underscored by
its presence in 61% of affected individuals.
According to the recently published gene map of the
HLA region (MHC Sequencing Consortium 1999), the
interval deﬁned by RH1 contains three transcription
units: NOB4, HCGII-2, and HCGIX-3. Although these
transcription units have been annotated as pseudogenes
on the HLAmap (MHC Sequencing Consortium 1999),
they are, nevertheless, candidates for the PSORS1 gene
and are under active investigation. However, because of
the high degree of polymorphism manifested by the
MHC, identiﬁcation of the true disease-causing se-
quence variant will likely require genomic-sequence
comparison of multiple nondisease chromosomes and
the disease chromosome. If this proves to be the case,
the relatively short length of RH1 (60 kb) should greatly
simplify the identiﬁcation of the PSORS1 gene.
The identiﬁcation of RH1 has important implications
for the population genetics of psoriasis. The existence
of ancestral haplotypes has been suggested to result
from suppression of recombination across certain seg-
ments of the MHC (Gaudieri et al. 1997) or to occur
as a reﬂection of natural selection for particular allele
combinations (Todd, in press). However, the results of
recent studies (Collins et al. 1999) have suggested that
the observed degree of linkage disequilibrium across the
HLA complex may not be markedly atypical for the
range of values exhibited by the human genome. Rather,
the existence of ancestral haplotypes may simply reﬂect
the origin of modernHomo sapiens from a limited foun-
der population thought to have migrated out of Africa
100,000–200,000 years ago (Jorde et al. 1998), coupled
with repeated population bottlenecks in the interim
(Collins et al. 1999). This “bottleneck hypothesis” is
attractive, since it can explain four curious features of
the population genetics of psoriasis. First, psoriasis is
associated with HLA-B13, HLA-B37, and HLA-B57 in
many world populations (Tsuji et al. 1992), and all of
these haplotypes carry Cw6 (reviewed in Elder et al.
1994). The data from the present study strongly suggest
that the EH57.1 haplotype is the oldest chromosome to
carry RH1 and that the Cw6-B13 and Cw6-B37 hap-
lotypes are associated with disease because they often
retain RH1. Second, there is a general correlation be-
tween the prevalence of psoriasis and that of Cw6, with
the prevalence of both being highest in northern Eur-
opeans, intermediate in Asian populations, and nearly
nonexistent in Amerindian populations (Farber and
Nall 1974; Yip 1984; Tsuji et al. 1992; Mallon et al.
1999; Youn et al. 1999). These phenomena would be
readily accounted for by genetic drift, with concomitant
loss of Cw6 and RH1. Third, Cw6 is a common allele
in Nigerians, Zimbabweans, and native black South Af-
ricans, among whom psoriasis is relatively uncommon.
Conversely, Cw6 is rare in other African populations in
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which psoriasis is common (Leder and Farber 1997).
However, the Cw6-B57, Cw6-B37, and Cw6-B13 hap-
lotypes are uncommon in Nigerians, Zimbabweans, and
black South Africans (Tsuji et al. 1992). A parsimonious
explanation would be that the RH1 disease determinant
was present in premigration Africa but that it existed
much closer to population equilibrium with HLA-C
than it does in present-day populations. Fourth, al-
though Cw6 carries a strongly increased relative risk of
psoriasis in nearly all populations tested (Mallon et al.
1999), the proportion of Cw6-positive psoriatics and
the associated relative risk varies substantially in dif-
ferent populations. While locus heterogeneity can ex-
plain variations in disease prevalence, it cannot explain
why the association of psoriasis appears to vary sub-
stantially among the various HLA-Cw6-Bx haplotypes
in geographically separated populations (Ozawa et al.
1981; Roitberg-Tambur et al. 1994; Ikaheimo et al.
1996; Kim et al. 2000). This observation could be ex-
plained by variable frequencies of recombination be-
tween Cw6 and RH1 in different population isolates.
Detailed studies of marker haplotypes across RH1 and
its ﬂanking regions in various world populations will
allow these theories to be tested.
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